Patents by Inventor Raymond Iezzi
Raymond Iezzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240374131Abstract: Described herein is a system and method for correcting a visual field of a subject using a predicted visual field that includes visual field defects from facial contours of the subject. In an embodiment. the predicted visual field may be determined using a three-dimensional (3D) reconstruction of the face of the subject which may be generated from a two-dimensional (2D) image of the subject using a convolution neural network. A system and method for optimizing a head turn angle of a subject for determining a visual field of a subject is also described herein. An optimal head turn angle may be determined using the 3D reconstruction of the face of the subject. In some embodiments, after the visual field is maximized with positioning of the head. residual facial contour induced defects can be predicted and a final corrected field can be generated.Type: ApplicationFiled: August 1, 2022Publication date: November 14, 2024Inventors: Cheryl L. Khanna, Raymond Iezzi, Jane M. Matsumoto
-
Patent number: 11874249Abstract: Embodiments of the invention include a method for manufacturing sensors and circuit structures. The method can include providing a substrate including a layer of polymer capable of producing graphite in response to the application of energy, a first electrode adjacent to a first via location on the layer of polymer, and an insulating layer over at least a portion of the first electrode and the layer of polymer at the first via location; and applying sufficient energy to the layer of polymer at the first via location through the insulating layer to ablate the insulating layer and to form a first via as mass of graphite that extends into electrical contact with the first electrode and is surrounded by the insulating layer in a plane of the insulating layer.Type: GrantFiled: August 23, 2018Date of Patent: January 16, 2024Assignee: Mayo Foundation for Medical Education and ResearchInventor: Raymond Iezzi
-
Publication number: 20230277728Abstract: This document provides methods and materials for performing retinal pigment epithelium transplantation. For example, methods and materials for using fibrin supports for retinal pigment epithelium transplantation are provided.Type: ApplicationFiled: March 29, 2023Publication date: September 7, 2023Applicant: Mayo Foundation for Medical Education and ResearchInventors: Alan D. Marmorstein, Raymond Iezzi, Jarel K. Gandhi, Jose S. Pulido
-
Patent number: 11684569Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.Type: GrantFiled: August 21, 2020Date of Patent: June 27, 2023Assignee: WAYNE STATE UNIVERSITYInventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Raja Guru, Sujatha Kannan
-
Patent number: 11679180Abstract: This document provides methods and materials for performing retinal pigment epithelium transplantation. For example, methods and materials for using fibrin supports for retinal pigment epithelium transplantation are provided.Type: GrantFiled: November 13, 2017Date of Patent: June 20, 2023Assignee: Mayo Foundation for Medical Education and ResearchInventors: Alan D. Marmorstein, Raymond Iezzi, Jarel K. Gandhi, Jose S. Pulido
-
Publication number: 20200393406Abstract: Embodiments of the invention include a method for manufacturing sensors and circuit structures. The method can include providing a substrate including a layer of polymer capable of producing graphite in response to the application of energy, a first electrode adjacent to a first via location on the layer of polymer, and an insulating layer over at least a portion of the first electrode and the layer of polymer at the first via location; and applying sufficient energy to the layer of polymer at the first via location through the insulating layer to ablate the insulating layer and to form a first via as mass of graphite that extends into electrical contact with the first electrode and is surrounded by the insulating layer in a plane of the insulating layer.Type: ApplicationFiled: August 23, 2018Publication date: December 17, 2020Inventor: Raymond Iezzi
-
Publication number: 20200390694Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.Type: ApplicationFiled: August 21, 2020Publication date: December 17, 2020Inventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Raja Guru, Sujatha Kannan
-
Publication number: 20200061246Abstract: This document provides methods and materials for performing retinal pigment epithelium transplantation. For example, methods and materials for using fibrin supports for retinal pigment epithelium transplantation are provided.Type: ApplicationFiled: November 13, 2017Publication date: February 27, 2020Applicant: Mayo Foundation for Medical Education and ResearchInventors: Alan D. Marmorstein, Raymond Iezzi, Jarel K. Gandhi, Jose S. Pulido
-
Patent number: 10463609Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.Type: GrantFiled: October 6, 2008Date of Patent: November 5, 2019Assignee: WAYNE STATE UNIVERSITYInventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Rajaguru, Sujatha Kannan
-
Publication number: 20170216200Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.Type: ApplicationFiled: February 23, 2017Publication date: August 3, 2017Inventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Rajaguru, Sujatha Kannan
-
Publication number: 20170056469Abstract: Methods are described for individualizing a patient's treatment for an eye disease that is mediated by vascular-derived endothelial growth factor.Type: ApplicationFiled: May 1, 2015Publication date: March 2, 2017Applicant: Mayo Foundation for Medical Education and ResearchInventor: Raymond Iezzi
-
Publication number: 20160279054Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.Type: ApplicationFiled: June 3, 2016Publication date: September 29, 2016Applicant: Wayne State UniversityInventors: Kannan Rangaramanujam, Bharath Raja Guru, Sujatha Kannan, Raymond Iezzi
-
Publication number: 20110034422Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.Type: ApplicationFiled: October 6, 2008Publication date: February 10, 2011Applicant: WAYNE STATE UNIVERSITYInventors: Rangaramanujam Kannan, Raymond Iezzi, Bharath Rajaguru, Sujatha Kannan
-
Patent number: 6853075Abstract: A self-assembled nanobump array structure including a semi-absorbing outer layer provided on at least one nanobump-forming substrate layer, the semi-absorbing outer layer configured to ablate slowly to allow an applied laser energy to be transmitted to the at least one nanobump-forming substrate layer, in which the self-assembled nanobump array structure is formed by an energy and a pressure buildup occurring in the at least one nanobump-forming substrate layer.Type: GrantFiled: January 28, 2003Date of Patent: February 8, 2005Assignee: Wayne State UniversityInventors: Gregory W. Auner, Ratna Naik, Simon Ng, Gary W. Abrams, James Patrick McCallister, Raymond Iezzi
-
Publication number: 20040145053Abstract: A self-assembled nanobump array structure including a semi-absorbing outer layer provided on at least one nanobump-forming substrate layer, the semi-absorbing outer layer configured to ablate slowly to allow an applied laser energy to be transmitted to the at least one nanobump-forming substrate layer, in which the self-assembled nanobump array structure is formed by an energy and a pressure buildup occurring in the at least one nanobump-forming substrate layer.Type: ApplicationFiled: January 28, 2003Publication date: July 29, 2004Inventors: Gregory W. Auner, Ratna Naik, Simon Ng, Gary W. Abrams, James Patrick McCallister, Raymond Iezzi
-
Patent number: 6668190Abstract: A drug delivery system includes a plurality of sites, a fluid channel for delivering a drug to one of the plurality sites, and a light channel for delivering light to an area near one of the plurality of sites. The fluid channel is a micro fluidic channel and the light channel is a wave guide. The light channel may also be a fiber optic cable. The light channel directs light at the fluid channel wherein light from the light channel does not substantially exit to the major surface. The drug delivery system selectively delivers drugs to various types of neurologic cells. In operation a solution of a photoactivatable neuro-active drug is delivered to a preselected area in vivo and photoactivated in the solution at the preselected area to stimulate neurological tissue. The neuro-active drug could be an antagonist or agonist of neuronal activity.Type: GrantFiled: June 14, 2001Date of Patent: December 23, 2003Assignee: Wayne State UniversityInventors: Raymond Iezzi, Greg Auner, Patrick McAllister, Gary W. Abrams
-
Publication number: 20020042638Abstract: A drug delivery system includes a plurality of sites, a fluid channel for delivering a drug to one of the plurality sites, and a light channel for delivering light to an area near one of the plurality of sites. The fluid channel is a micro fluidic channel and the light channel is a wave guide. The light channel may also be a fiber optic cable. The light channel directs light at the fluid channel wherein light from the light channel does not substantially exit to the major surface. The drug delivery system selectively delivers drugs to various types of neurologic cells. In operation a solution of a photoactivatable neuro-active drug is delivered to a preselected area in vivo and photoactivated in the solution at the preselected area to stimulate neurological tissue. The neuro-active drug could be an antagonist or agonist of neuronal activity.Type: ApplicationFiled: June 14, 2001Publication date: April 11, 2002Inventors: Raymond Iezzi, Greg Auner, Patrick McAllister, Gary W. Abrams
-
Patent number: 5551432Abstract: An ultrasonic probe which performs a two-dimensional scan is supported by a mount having a thread which is driven back and forth by a screw along a third axis. When a two-dimensional scan is completed in a first plane, a motor drives the mount along a guide to a second plane for the next scan. The separation between the planes being the same as the resolution in scanning within a plane. A housing having a slot with sidewalls is employed to guide the mount in traveling to successive plane locations along its axis. Means for orienting the housing in angular position and a support assembly provide moveable support to the orienting means so that minimal force is required to position the probe relative to the patient. An "auto-scroll" feature permits the operator to interactively pan through multiple, adjacent two-dimensional planes at programmable speeds and displacements along a third axis.Type: GrantFiled: June 19, 1995Date of Patent: September 3, 1996Assignee: New York Eye & Ear InfirmaryInventor: Raymond Iezzi